TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
BDTX

Black Diamond Therapeutics Inc

Healthcare · Biotechnology

1.90$ -0.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Black Diamond Therapeutics Inc (BDTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 125 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BDTX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
172 159 143 150 138 123 176 166 158 143 133 125
147 134 119 127 116 101 156 147 139 132 123 115
58 56 25 33 23 36 98 30 31 21 30 19
144 131 115 123 113 99 152 143 136 129 118 111
38 42 38 39 40 39 35 34 32 31 29 29
15 20 17 18 21 21 17 17 16 16 15 16
3.0 3.1 3.2 3.3 3.3 3.4 3.7 3.8 3.6 3.7 3.8 3.9
0.7 2.3 1.2 0.8 2.0 4.0 2.6 0.8 1.0 0.6 3.0 1.4
134 117 104 111 97 83 142 133 126 112 104 96
-398 -417 -436 -456 -471 -487 -431 -441 -450 -465 -474 -484
51 47 52 55 57 57 58 57 57 57 57 57

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?